Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 337 entries
View as:

Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT06089577 Org: User:
Start: 11/01/23 End: 10/31/26 Due: 10/31/27

Videolaryngoscopes for Tracheal Intubation

Phase: N/A Priority: Normal
NCT ID: NCT02897518 Org: User:
Start: 01/31/15 End: 01/31/16 Due: 01/31/17

Physical Examination-Indicated Pessary

Phase: N/A Priority: Normal
NCT ID: NCT02967445 Org: User:
Start: 11/30/16 End: 03/31/18 Due: 03/31/19

Effects of Growth Hormone on Exercise Capacity

Phase: N/A Priority: Normal
NCT ID: NCT00501514 Org: User:
Start: 11/30/97 End: 11/30/05 Due: 11/30/06

Prediction of Tumor Shrinkage in Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00616408 Org: User:
Start: 01/31/97 End: 12/31/07 Due: 12/31/08

Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy

Phase: N/A Priority: Normal
NCT ID: NCT02149134 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

Evaluation of an Intra Auricular Device as a Treatment for Painful Temporo-Mandibular Disorders

Phase: N/A Priority: Normal
NCT ID: NCT05365932 Org: User:
Start: 11/29/18 End: 12/10/19 Due: 12/10/20

The Quality of Life of Mothers of Children With Food Allergy

Phase: N/A Priority: Normal
NCT ID: NCT04740632 Org: User:
Start: 01/10/22 End: 01/10/23 Due: 01/10/24

Calcium and Vitamin D Intakes in Children

Phase: N/A Priority: Normal
NCT ID: NCT01638494 Org: User:
Start: 12/31/08 End: 02/28/09 Due: 02/28/10

24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS C

Phase: N/A Priority: Normal
NCT ID: NCT01517308 Org: User:
Start: 05/31/12 End: 11/30/15 Due: 11/30/16

Mechanical Ventilation- Weaning and Thoracic Impedance Tomography

Phase: N/A Priority: Normal
NCT ID: NCT03018483 Org: User:
Start: 05/01/17 End: 12/01/19 Due: 12/01/20

Exercise in Pregnancy and Risk of Postpartum Depression

Phase: N/A Priority: Normal
NCT ID: NCT06355375 Org: User:
Start: 03/22/24 End: 12/01/25 Due: 12/01/26

n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01876875 Org: User:
Start: 04/30/07 End: 10/31/08 Due: 10/31/09

Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT03863418 Org: User:
Start: 05/15/19 End: 12/31/20 Due: 12/31/21

Study of Retinal and Choriocapillary Vascular Changes in Patients Undergoing Tadalafil 20mg for More Than 6 Months

Phase: N/A Priority: Normal
NCT ID: NCT04491773 Org: User:
Start: 11/01/19 End: 05/30/20 Due: 05/30/21

From Nature to Bedside- Algae Based Bio Compound for Prevention and Treatment of Inflammation, Pain and IBD

Phase: N/A Priority: Normal
NCT ID: NCT06227598 Org: User:
Start: 05/01/24 End: 09/01/26 Due: 09/01/27

Surgical Stress and Intracorporeal Anastomosis

Phase: N/A Priority: Normal
NCT ID: NCT03422588 Org: User:
Start: 01/01/17 End: 12/01/19 Due: 12/01/20

Human IgGs and Endothelial Function in Vivo in Humans

Phase: N/A Priority: Normal
NCT ID: NCT03534479 Org: User:
Start: 04/30/10 End: 04/30/13 Due: 04/30/14

Follow Up of High Risk Hodgkin Lymphoma in First Complete Remission

Phase: N/A Priority: Normal
NCT ID: NCT04298619 Org: User:
Start: 06/30/01 End: 04/30/19 Due: 04/30/20

Microbiota as Potential Target for Food Allergy

Phase: N/A Priority: Normal
NCT ID: NCT02087930 Org: User:
Start: 03/31/13 End: 09/30/20 Due: 09/30/21

The ELYAR (Elysium Against Rhinitis) Project

Phase: N/A Priority: Normal
NCT ID: NCT06757179 Org: User:
Start: 12/01/23 End: 07/31/24 Due: 07/31/25

Management of Heart Failure in Italian Outpatients Clinics: Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT06287164 Org: User:
Start: 03/01/23 End: 02/01/25 Due: 02/01/26

Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS

Phase: N/A Priority: Normal
NCT ID: NCT04739384 Org: User:
Start: 04/01/21 End: 06/20/22 Due: 06/20/23

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

Phase: N/A Priority: Normal
NCT ID: NCT06295211 Org: User:
Start: 09/01/13 End: 02/22/24 Due: 02/22/25

Gut Microbiome and Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04451148 Org: User:
Start: 05/01/20 End: 05/01/22 Due: 05/01/23